Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae763 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Qinglei Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Geriatric Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou…. Hauptthemen laut MEDLINE: Graves Disease, Graves Ophthalmopathy, Immune Checkpoint Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Program of Guangzhou, China, Young Talent Support Project of Guangzhou Association for Science and Technology.
Abstract (Originalsprache)
Context
Soluble immune checkpoints play an important role in peripheral tolerance that has seldom been investigated in Graves' disease (GD) and thyroid eye disease (TED).
Objective
The objective of this work is to examine the alteration of soluble immune checkpoints in GD and TED.
Methods
We performed a quantitative multiplex analysis of 17 immune checkpoint proteins in serum from 50 GD patients without TED, 28 GD patients with TED, and 40 healthy controls. The association with demographic, serologic, clinical features and 27 cytokines was analyzed. A follow-up was conducted in GD patients without TED. Functional outcomes of sLAG-3 and sGITR were assessed in cell cultures using rh-LAG3, rh-GITR, an antagonistic LAG-3 antibody, and an antagonistic GITR antibody.
Results
GD Patients with TED had distinct sICP and cytokine profiles compared with GD patients without TED. Active patients with TED exhibited elevation in the levels of sBTLA, sLAG-3, sGITR, sCD80, sCD86, and sPD-L1. Further, GD patients without TED with high sBTLA, sCD27, and sCD40 levels at baseline showed a better improvement in thyrotropin receptor antibody titers after antithyroid drug treatment. Adding recombinant human GITR and LAG-3 to peripheral blood mononuclear cell cultures resulted in increased inflammatory cytokine secretion and decreased anti-inflammatory cytokine secretion.
Conclusion
The present study uncovers disturbed soluble immune checkpoints and cytokines in GD patients with and without TED and may pave the way for novel immunological screening, allowing for identification of patients with TED at higher risk of developing active disease and patients with GD a better treatment response after antithyroid drug treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Geriatric Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
- Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200011, China.
- Reproductive Medicine Center, Department of Obstetrics and Gynecology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
- Department of Endocrinology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
ORCID-Profile: Qinglei Yin, Sijie Fang, Huifang Zhou, Haixia Guan
Förderung
- National Natural Science Foundation of China
- Science and Technology Program of Guangzhou, China
- Young Talent Support Project of Guangzhou Association for Science and Technology
Zitieren
APA
Yin, Q., Zhu, T., Song, D., Fang, S., Zhou, H., & Guan, H. (2025). Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae763
Vancouver
Yin Q, Zhu T, Song D, Fang S, Zhou H, Guan H. Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae763
BibTeX
@article{Yin2025,
author = {Yin, Qinglei and Zhu, Tianyi and Song, Dalong and Fang, Sijie and Zhou, Huifang and Guan, Haixia},
title = {Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae763}
}
EUVIMED